0001816590-22-000008.txt : 20220204 0001816590-22-000008.hdr.sgml : 20220204 20220204155633 ACCESSION NUMBER: 0001816590-22-000008 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220201 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220204 DATE AS OF CHANGE: 20220204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COMPASS Pathways plc CENTRAL INDEX KEY: 0001816590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39522 FILM NUMBER: 22593060 BUSINESS ADDRESS: STREET 1: 3RD FLOOR, 1 ASHLEY ROAD STREET 2: ALTRINCHAM CITY: CHESIRE STATE: X0 ZIP: WA14 2DT BUSINESS PHONE: 1-646-905-3974 MAIL ADDRESS: STREET 1: 3RD FLOOR, 1 ASHLEY ROAD STREET 2: ALTRINCHAM CITY: CHESIRE STATE: X0 ZIP: WA14 2DT FORMER COMPANY: FORMER CONFORMED NAME: Compass Rx Ltd. DATE OF NAME CHANGE: 20200701 8-K 1 cmps-20220201.htm 8-K cmps-20220201
false000181659000018165902022-02-012022-02-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 1, 2022
COMPASS PATHWAYS PLC
(Exact Name of Registrant as Specified in Its Charter)
England and Wales
(State or Other Jurisdiction of Incorporation)
England and Wales001-39522Not applicable
(State or other Jurisdiction of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)

33 Broadwick Street
London W1F 0DQ
United Kingdom
(Address of Principal Executive Offices; Zip Code)
+1 (646) 905-3974
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:

Title of each class 
Trading
Symbol(s)
 Name of each exchange on which registered
American Depositary Shares, each representing one ordinary share, nominal value £0.008 per share CMPS The Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
In connection with certain awards that may be granted from time to time under the COMPASS Pathways plc 2020 Share Option and Incentive Plan (the “Plan”), the Compensation and Leadership Development Committee (the “Committee”) of COMPASS Pathways plc (the “Company”) has adopted the following forms of award agreements: (i) Restricted Share Unit Award Agreement for Company Employees (the “RSU Award Agreement”) and (ii) Non-Qualified Share Option Agreement for Company Employees (the “Option Award Agreement”), copies of which are filed herewith as Exhibits 10.1 and 10.2, respectively, and incorporated by reference into this Item 5.02(e) as though fully set forth herein.
Each of the RSU Award Agreement and Option Award Agreement (a) provides for the grant of RSUs or options, respectively, to eligible participants under the Plan, which may, among other things, be subject to (i) vesting in accordance with the vesting schedule provided in the applicable grant notice and (ii) certain transfer restrictions, and (b) authorizes the Company to cause shares to be sold on the participant’s account to cover applicable withholding taxes due upon vesting of the shares underlying the RSUs or options, as applicable.
In addition, effective February 1, 2022, the Committee awarded (i) 173,000 options to George Goldsmith and 75,000 options to Ekaterina Malievskaia pursuant to the Option Award Agreement and (ii) 29,000 RSUs to George Goldsmith and 13,000 RSUs to Ekaterina Malievskaia pursuant to the RSU Award Agreement. Each option and RSU represents the right to receive one Share (as defined in the Plan) upon vesting. The options vest in 48 equal monthly installments commencing one month from the grant date, subject to the individual’s continued service to the Company through the applicable vesting date, and are subject to the terms and conditions of the Company’s Option Award Agreement under the Plan. The RSUs vest in four equal annual installments commencing on the one year anniversary of the grant date, subject to the individual’s continued service to the Company through the applicable vesting date, and are subject to the terms and conditions of the Company’s RSU Award Agreement under the Plan.

Item 9.01.Financial Statements and Exhibits.
(d)Exhibits.
The following exhibits are filed herewith:


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
COMPASS PATHWAYS PLC
Date: February 4, 2022By:/s/ Michael Falvey
Michael Falvey
Chief Financial Officer

 EX-10.1 2 exhibit101formofrestricted.htm EX-10.1 Document

RESTRICTED SHARE UNIT AWARD AGREEMENT
FOR COMPANY EMPLOYEES
UNDER THE COMPASS PATHWAYS PLC
2020 SHARE OPTION AND INCENTIVE PLAN
Name of Grantee:        
No. of Restricted Share Units:        
Grant Date:    February 1, 2022
Vesting Commencement Date:    Grant Date

Pursuant to the COMPASS Pathways plc 2020 Share Option and Incentive Plan, as amended through the date hereof (the “Plan”), COMPASS Pathways plc (the “Company”) hereby grants an award of the number of Restricted Share Units listed above (an “Award”) to the Grantee named above. Each Restricted Share Unit shall relate to one Share.
1.Restrictions on Transfer of Award. This Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of by the Grantee, and any Shares issuable with respect to the Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of until (i) the Restricted Share Units have vested as provided in Paragraph 2 of this Agreement and (ii) Shares have been issued to the Grantee in accordance with the terms of the Plan and this Agreement.
2.Vesting of Restricted Share Units. The restrictions and conditions of Paragraph 1 of this Agreement shall lapse on the specified dates in the following schedule (each, a “Vesting Date”) so long as the Grantee remains an employee of the Company or any Subsidiary on such Vesting Date(s): in four equal annual installments commencing with the one-year anniversary of the Vesting Commencement Date.
The Administrator may at any time accelerate the vesting schedule specified in this Paragraph 2.
3.Termination of Employment. If the Grantee’s employment terminates for any reason (including death or disability) prior to a Vesting Date set forth in Paragraph 2 above, any Restricted Share Units that have not vested as of such date shall automatically and without notice terminate and be forfeited, and neither the Grantee nor any of his or her successors, heirs, assigns, or personal representatives will thereafter have any further rights or interests in such unvested Restricted Share Units.
4.Issuance of Shares. As soon as practicable following each Vesting Date (but in no event later than two and one-half months after the end of the year in which the Vesting Date occurs), the Company shall issue to the Grantee the number of Shares equal to the aggregate number of Restricted Share Units that have vested pursuant to Paragraph 2 of this Agreement on such date and the Grantee shall thereafter have all the rights of a shareholder of the Company with respect to such shares.
5.Incorporation of Plan. Notwithstanding anything herein to the contrary, this Agreement shall be subject to and governed by all the terms and conditions of the Plan, including


the powers of the Administrator set forth in Section 2(b) of the Plan. Capitalized terms in this Agreement shall have the meaning specified in the Plan, unless a different meaning is specified herein.
6.Tax Withholding. The Grantee shall, not later than the date as of which the receipt of this Award becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the Administrator for payment of any Federal, state, and local taxes required by law to be withheld on account of such taxable event. The Company shall have the authority to cause the required tax withholding obligation to be satisfied, in whole or in part, by withholding from Shares to be issued to the Grantee a number of Shares with an aggregate Fair Market Value that would satisfy the withholding amount due (provided that such amount shall not exceed the maximum statutory amount due).
7.Section 409A of the U.S. Code. This Agreement shall be interpreted in such a manner that all provisions relating to the settlement of the Award are exempt from the requirements of Section 409A of the U.S. Code as “short-term deferrals” as described in Section 409A of the U.S. Code.
8.No Obligation to Continue Employment. Neither the Company nor any Subsidiary is obligated by or as a result of the Plan or this Agreement to continue the Grantee’s Service Relationship and neither the Plan nor this Agreement shall interfere in any way with the right of the Company or any Subsidiary to terminate the Service Relationship of the Grantee at any time.
9.Integration. This Agreement constitutes the entire agreement between the parties with respect to this Award and supersedes all prior agreements and discussions between the parties concerning such subject matter.
10.Section 431 Election. If the Grantee is tax resident in the United Kingdom and is so requested by the Board, the Grantee shall, along with its employer, within 14 days of acquisition of any Shares enter into a Section 431 Election with respect to such Shares enter into a Section 431 Election with respect to such Shares. The Grantee shall also make such arrangements as the Board may require for the satisfaction of any Federal, state, or local taxes (domestic or foreign) of any kind (including, but not limited to, any United Kingdom income tax or National Insurance contributions and including (to the extent legally permissible) with any employer’s (secondary) National Insurance contributions) with respect to such acquisition of Shares as may arise upon the making of such Section 431 Election.
11.Data Privacy Consent. In order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents thereof (together, the “Relevant Companies”) may process any and all personal or professional data, including but not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan and/or this Agreement (the “Relevant Information”). By entering into this Agreement, the Grantee (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Grantee may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant Companies consider appropriate. The Grantee shall have access to, and the right to change, the Relevant Information. Relevant Information will only be used in accordance with applicable law.
    2

12.Notices. Notices hereunder shall be mailed or delivered to the Company at its principal place of business and shall be mailed or delivered to the Grantee at the address on file with the Company or, in either case, at such other address as one party may subsequently furnish to the other party in writing.
    3

COMPASS PATHWAYS PLC
By:        
    Title:
The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned. Electronic acceptance of this Agreement pursuant to the Company’s instructions to the Grantee (including through an online acceptance process) is acceptable.
Dated:                
Grantee’s Signature

Grantee’s name and address:
    
    
    
    4
 EX-10.2 3 exhibit102formofnon-qualif.htm EX-10.2 Document

NON-QUALIFIED SHARE OPTION AGREEMENT
FOR COMPANY EMPLOYEES
UNDER THE COMPASS PATHWAYS PLC
2020 SHARE OPTION AND INCENTIVE PLAN
Name of Optionee:    
No. of Option Shares:    
Option Exercise Price per Share:    $[FMV on Grant Date]
Grant Date:    February 1, 2022    
Vesting Commencement Date:    Grant Date

Expiration Date:    January 31, 2032    
Pursuant to the COMPASS Pathways plc 2020 Share Option and Incentive Plan, as amended through the date hereof (the “Plan”), COMPASS Pathways plc (the “Company”) hereby grants to the Optionee named above an option (the “Share Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of Shares specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Share Option is not intended to be an “incentive stock option” under Section 422 of the U.S. Internal Revenue Code of 1986, as amended.
1.Vesting and Exercisability Schedule. No portion of this Share Option may be exercised until such portion shall have vested become exercisable. Except as set forth below, and subject to the discretion of the Administrator (as defined in Section 2 of the Plan) to accelerate the exercisability schedule hereunder, this Share Option shall become vested and exercisable as follows, so long as Optionee remains an employee of the Company or any Subsidiary on such dates: in 48 equal monthly installments commencing with the one-month anniversary of the Vesting Commencement Date.
Once vested and exercisable, this Share Option shall continue to be exercisable at any time or times prior to the close of business on the Expiration Date, subject to the provisions hereof and of the Plan.
2.Manner of Exercise.
(a)The Optionee may exercise this Share Option only in the following manner: from time to time on or prior to the Expiration Date of this Share Option, the Optionee may give written notice to the Administrator of his or her election to purchase some or all of the Option Shares purchasable at the time of such notice. This notice shall specify the number of Option Shares to be purchased.
Payment of the purchase price for the Option Shares may be made by one or more of the following methods: (i) in cash, by certified or bank check or other instrument acceptable to the Administrator; (ii) through the delivery (or attestation to the ownership) of Shares that have been purchased by the Optionee on the open market or that are beneficially owned by the Optionee and are not then subject to any restrictions under any Company plan and that otherwise satisfy any holding periods as may be required by the Administrator; (iii) by the Optionee delivering to


the Company a properly executed exercise notice together with irrevocable instructions to a broker to promptly deliver to the Company cash or a check payable and acceptable to the Company to pay the option purchase price, provided that in the event the Optionee chooses to pay the option purchase price as so provided, the Optionee and the broker shall comply with such procedures and enter into such agreements of indemnity and other agreements as the Administrator shall prescribe as a condition of such payment procedure; (iv) by a “net exercise” arrangement pursuant to which the Company will reduce the number of Shares issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price; or (v) a combination of (i), (ii), (iii) and (iv) above. Payment instruments will be received subject to collection.
The transfer to the Optionee on the records of the Company or of the transfer agent of the Option Shares will be contingent upon (i) the Company’s receipt from the Optionee of the full purchase price for the Option Shares, as set forth above, (ii) the fulfillment of any other requirements contained herein or in the Plan or in any other agreement or provision of laws, and (iii) the receipt by the Company of any agreement, statement or other evidence that the Company may require to satisfy itself that the issuance of Shares to be purchased pursuant to the exercise of Share Options under the Plan and any subsequent resale of the Shares will be in compliance with applicable laws and regulations. In the event the Optionee chooses to pay the purchase price by previously-owned Shares through the attestation method, the number of Shares transferred to the Optionee upon the exercise of the Share Option shall be net of the Shares attested to.
(b)The Shares purchased upon exercise of this Share Option shall be transferred to the Optionee on the records of the Company or of the transfer agent upon compliance to the satisfaction of the Administrator with all requirements under applicable laws or regulations in connection with such transfer and with the requirements hereof and of the Plan. The determination of the Administrator as to such compliance shall be final and binding on the Optionee. The Optionee shall not be deemed to be the holder of, or to have any of the rights of a holder with respect to, any Shares subject to this Share Option unless and until this Share Option shall have been exercised pursuant to the terms hereof, the Company or the transfer agent shall have transferred the shares to the Optionee, and the Optionee’s name shall have been entered as the shareholder of record on the books of the Company. Thereupon, the Optionee shall have full voting, dividend and other ownership rights with respect to such Shares.
(c)Notwithstanding any other provision hereof or of the Plan, no portion of this Share Option shall be exercisable after the Expiration Date hereof.
3.Termination of Employment. If the Optionee’s employment by the Company or a Subsidiary (as defined in the Plan) is terminated, the period within which to exercise the Stock Option may be subject to earlier termination as set forth below.
(a)Termination Due to Death. If the Optionee’s employment terminates by reason of the Optionee’s death, any portion of this Stock Option outstanding on such date, to the extent exercisable on the date of death, may thereafter be exercised by the Optionee’s legal representative or legatee for a period of 12 months from the date of death or until the Expiration Date, if earlier. Any portion of this Stock Option that is not exercisable on the date of death shall terminate immediately and be of no further force or effect.
(b)Termination Due to Disability. If the Optionee’s employment terminates by reason of the Optionee’s disability (as determined by the Administrator), any portion of this Stock Option outstanding on such date, to the extent exercisable on the date of such termination of employment, may thereafter be exercised by the Optionee for a period of 12 months from the date of disability or until the Expiration Date, if earlier. Any portion of this Stock Option that is
    2

not exercisable on the date of disability shall terminate immediately and be of no further force or effect.
(c)Termination for Cause. If the Optionee’s employment terminates for Cause, any portion of this Stock Option outstanding on such date shall terminate immediately and be of no further force and effect. For purposes hereof, “Cause” shall mean, unless otherwise provided in an employment agreement between the Company and the Optionee, a determination by the Administrator that the Optionee shall be dismissed as a result of (i) any material breach by the Optionee of any agreement between the Optionee and the Company; (ii) the conviction of, indictment for or plea of nolo contendere by the Optionee to a felony or a crime involving moral turpitude; or (iii) any material misconduct or willful and deliberate non-performance (other than by reason of disability) by the Optionee of the Optionee’s duties to the Company.
(d)Other Termination. If the Optionee’s employment terminates for any reason other than the Optionee’s death, the Optionee’s disability or Cause, and unless otherwise determined by the Administrator, any portion of this Stock Option outstanding on such date may be exercised, to the extent exercisable on the date of termination, for a period of three months from the date of termination or until the Expiration Date, if earlier.
Any portion of this Share Option that is not vested and exercisable on the date of termination shall, unless otherwise determined by the Administrator, terminate immediately and be of no further force or effect. The Administrator’s determination of the reason for termination of the Optionee’s employment shall be conclusive and binding on the Optionee and his or her representatives or legatees.
4.Incorporation of Plan. Notwithstanding anything herein to the contrary, this Share Option shall be subject to and governed by all the terms and conditions of the Plan, including the powers of the Administrator set forth in Section 2(b) of the Plan. Capitalized terms in this Agreement shall have the meaning specified in the Plan, unless a different meaning is specified herein.
5.Transferability. This Agreement is personal to the Optionee, is non-assignable and is not transferable in any manner, by operation of law or otherwise, other than by will or the laws of descent and distribution. This Share Option is exercisable, during the Optionee’s lifetime, only by the Optionee, and thereafter, only by the Optionee’s legal representative or legatee.
6.Tax Withholding. The Optionee shall, not later than the date as of which the exercise of this Share Option becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the Administrator for payment of any Federal, state, and local taxes required by law to be withheld on account of such taxable event. The Company shall have the authority to cause the required tax withholding obligation to be satisfied, in whole or in part, by withholding from Shares to be issued to the Optionee a number of Shares with an aggregate Fair Market Value that would satisfy the withholding amount due (provided that such amount shall not exceed the maximum statutory tax rate).
7.UK Taxes. No Shares will be delivered to the Optionee pursuant to the exercise of the Share Option until the Optionee has made arrangements acceptable to the Company for the satisfaction of any applicable domestic or foreign income tax and employment tax of any kind (including, but not limited to, any United Kingdom income tax or National Insurance contributions) required by law to be paid or withheld by the Company or any Subsidiary, including, without limitation, such other tax obligations of the Optionee incidental to the receipt of Shares, together (to the extent legally permissible) with any employer’s (secondary) National Insurance contributions which may arise with respect this Agreement. Upon exercise of the
    3

Share Option, the Company or the Optionee’s employer may offset or withhold (from any amount owed by the Company or the Optionee’s employer to the Optionee) or collect from the Optionee an amount sufficient to satisfy such tax or withholding obligations. Furthermore, in the event of any determination that the Company or any Subsidiary has failed to withhold a sum sufficient to pay all taxes due in connection with the Share Option, the Optionee agrees to pay to the Company or the relevant Subsidiary such amount in cash within five (5) days after receiving a written demand from the Company or the relevant Subsidiary to do so, whether or not the Optionee is an employee of the Company or such Subsidiary at that time.
8.Transfer of Burden of Employer’s National Insurance contributions. If the Optionee is tax resident in the United Kingdom (a “UK Participant”), the Optionee agrees with and undertakes to the Company and, if different, to its employer that:
(i)The Optionee’s employer may recover from the Optionee, as set out in Section 3 above, the whole or any part of any employer’s (secondary) National Insurance contributions which may arise with respect to any taxable event arising as a result of this Agreement; and
(ii)The Optionee shall, if requested by the Company, join with its employer in making an election (in a form approved by HMRC under paragraph 3B of Schedule 1 to the Social Security Contributions and Benefits Act 1992) for the transfer to the Optionee of the whole, or such part as the Company may determine, of any liability to employer’s (secondary) National Insurance contributions which may arise with respect to any taxable event arising as a result of this Agreement.
9.No Obligation to Continue Employment. Neither the Company nor any Subsidiary is obligated by or as a result of the Plan or this Agreement to continue the Optionee’s Service Relationship and neither the Plan nor this Agreement shall interfere in any way with the right of the Company or any Subsidiary to terminate the Service Relationship of the Optionee at any time.
10.Integration. This Agreement constitutes the entire agreement between the parties with respect to this Share Option and supersedes all prior agreements and discussions between the parties concerning such subject matter.
11.Data Privacy Consent. In order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents thereof (together, the “Relevant Companies”) may process any and all personal or professional data, including but not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan and/or this Agreement (the “Relevant Information”). By entering into this Agreement, the Optionee (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Optionee may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant Companies consider appropriate. The Optionee shall have access to, and the right to change, the Relevant Information. Relevant Information will only be used in accordance with applicable law.
12.Notices. Notices hereunder shall be mailed or delivered to the Company at its principal place of business and shall be mailed or delivered to the Optionee at the address on file with the Company or, in either case, at such other address as one party may subsequently furnish to the other party in writing.
    4

COMPASS PATHWAYS PLC
By:        
    Title:
The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned. Electronic acceptance of this Agreement pursuant to the Company’s instructions to the Optionee (including through an online acceptance process) is acceptable.
Dated:                
Optionee’s Signature

Optionee’s name and address:
    
    
        
    
    
    

    5
 EX-101.SCH 4 cmps-20220201.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 cmps-20220201_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, Address Line One Entity Address, Address Line One Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Written Communications Written Communications Local Phone Number Local Phone Number Soliciting Material Soliciting Material City Area Code City Area Code Document Type Document Type Entity Address, Country Entity Address, Country Document Period End Date Document Period End Date Cover [Abstract] Country Region Country Region Entity Address, City or Town Entity Address, City or Town Entity Central Index Key Entity Central Index Key Pre-commencement Tender Offer Pre-commencement Tender Offer Entity File Number Entity File Number Amendment Flag Amendment Flag Trading Symbol Trading Symbol Entity Emerging Growth Company Entity Emerging Growth Company Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code EX-101.PRE 6 cmps-20220201_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Cover
Feb. 01, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Feb. 01, 2022
Entity Registrant Name COMPASS PATHWAYS PLC
Entity Incorporation, State or Country Code X0
Entity File Number 001-39522
Entity Address, Address Line One 33 Broadwick Street
Entity Address, City or Town London
Entity Address, Postal Zip Code W1F 0DQ
Entity Address, Country GB
Country Region 1
City Area Code 646
Local Phone Number 905-3974
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security American Depositary Shares, each representing one ordinary share, nominal value £0.008 per share
Trading Symbol CMPS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001816590
XML 8 cmps-20220201_htm.xml IDEA: XBRL DOCUMENT 0001816590 2022-02-01 2022-02-01 false 0001816590 8-K 2022-02-01 COMPASS PATHWAYS PLC X0 001-39522 33 Broadwick Street London W1F 0DQ GB 1 646 905-3974 false false false false American Depositary Shares, each representing one ordinary share, nominal value £0.008 per share CMPS NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 1 123 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://compasspathways.com/role/Cover Cover Cover 1 false false All Reports Book All Reports cmps-20220201.htm cmps-20220201.xsd cmps-20220201_lab.xml cmps-20220201_pre.xml exhibit101formofrestricted.htm exhibit102formofnon-qualif.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cmps-20220201.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "cmps-20220201.htm" ] }, "labelLink": { "local": [ "cmps-20220201_lab.xml" ] }, "presentationLink": { "local": [ "cmps-20220201_pre.xml" ] }, "schema": { "local": [ "cmps-20220201.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 123, "memberCustom": 0, "memberStandard": 0, "nsprefix": "cmps", "nsuri": "http://compasspathways.com/20220201", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cmps-20220201.htm", "contextRef": "iffe2985c5e85411fadbee5a8a219f807_D20220201-20220201", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://compasspathways.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cmps-20220201.htm", "contextRef": "iffe2985c5e85411fadbee5a8a219f807_D20220201-20220201", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region", "terseLabel": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://compasspathways.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001816590-22-000008-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001816590-22-000008-xbrl.zip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